Dan Groman - May 22, 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
May 22, 2023
Transactions value $
-$426,516
Form type
4
Date filed
5/24/2023, 04:16 PM
Previous filing
May 12, 2023
Next filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Sale -$31K -3.88K -4.86% $8.00 75.9K May 22, 2023 Direct F1
transaction ENFN Class A Common Stock Sale -$396K -50K -65.85% $7.91 25.9K May 22, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2022.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.90 to $7.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.